Startup · $15.8m raised
Every investor coverage indicates participated in a round Apromore (exited) raised.
| Investor | Rounds | Invested |
|---|---|---|
| GBTEC | Series B | - |
| Salesforce | Series B | - |
Investors whose own portfolio pages list Apromore (exited), even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Tin Alley Ventures | its portfolio page ↗ |
Companies Apromore (exited) acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Marcello La Rosa | CEO | Startup Daily |
Stories naming Apromore (exited). Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Techboard's monthly roundup catalogues December 2022 startup raises, led by Synchron's $110m Series C, with health and biotech taking the largest share and 55 funding events captured totalling $546m.
A weekly roundup reporting ten Australian startup funding rounds totalling roughly eighty million dollars, spanning insurance tech, biotech, process mining, connectivity and food, with several female-founded companies among the recipients.
Process mining startup Apromore, spun out of Melbourne University, raised US$10.3 million (A$15.8 million) in Series B funding from Salesforce and GBTEC, and announced a product partnership with Salesforce.
Also SmartCompany·Techboard